Our findings indicated that MCL markedly suppressed COL1A1 and FN expression in liver tissue (Figure 1H,I), suggesting its considerable therapeutic potential for hepatic fibrosis treatment. This evidence concerns the gene FN1 and Hepatic fibrosis.